pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4662b |
Genomic Coordinates | chr8: 124821978 - 124822058 |
Description | Homo sapiens miR-4662b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4662b | |||||||||||||||||||||
Sequence | 50| AAAGAUGGACAAUUGGCUAAAU |71 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ASPH | ||||||||||||||||||||
Synonyms | AAH, BAH, CASQ2BP1, FDLAB, HAAH, JCTN, junctin | ||||||||||||||||||||
Description | aspartate beta-hydroxylase | ||||||||||||||||||||
Transcript | NM_001164750 | ||||||||||||||||||||
Other Transcripts | NM_001164751 , NM_001164752 , NM_001164753 , NM_001164754 , NM_001164755 , NM_001164756 , NM_004318 , NM_020164 , NM_032466 , NM_032467 , NM_032468 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ASPH | |||||||||||||||||||||
3'UTR of ASPH (miRNA target sites are highlighted) |
>ASPH|NM_001164750|3'UTR 1 CATGAATTCATGCAAGCTTGGGAAACTCTGGAGAGAGGCTGCCTTTCTGGTTCCATCTCCTTGGGTGTGAGGATAGAATT 81 TCGAACACCAAGAGTCAATTCCCTTGACTTGCAGCCCGAGTAATTCAAAGCCTCCTCCTAGGGTCAGAAGACACTAAAGG 161 GAATATTTGCCTCGCTGCAATTCATTTAGGAAACACCCTGCTGTGTGTCATCTCATGACAGCACTGGTCTTCTGCCAGTA 241 TTTAAGGTGAACATTTGATAGCTTCTACCTTACCAGCCAAAGATATTTTTTCCACATAGAATAGGTCTAATTCAATGTAT 321 AATGAGAACATATGTAGAAACTGTGAATGGATTGCTTTAGTTTGTAATTTTTCTATGCAGTTATATTTTTCTAGTGTAGC 401 TAGACTATTTTGTCATCATGTACCACTACATTTTTGTTTATTTTAATGACAAGCTGTATAAATGCTTTACTTCTAGCTAT 481 TTAATGGTAGCATTACTGGGGAACTCAGACTTCCCTCTTTTAATTCTTCTTAGTAAAAGATACTCATGAAAAAAGCAGTT 561 TTATTTTCCTAACAAAAAAGAAAGAGCTCATTATGTCAGTGTCTATGAACTGTACCCATCCCAACTCTCAAATCGTTTGG 641 TTTTTTTTATCTTGATTGAGATCCTCTTCTCACTATGCTAGTGGTGGAGATATTGACAAAATCCTATTTCTTTCAAAGAG 721 GAACTTTTCACACCGAAAAAAGAGCATGGAATTATTTTATATTGTTATAAAAATCCCAGATGCAAATTTTTTTAATGCCA 801 ATTATTAGAGCTTCTGGGGAAAAAGTATAGTTCACGGAAATAAAACTATGTTCTTTCAGGGTTGGGTGGATAGGTGGCTG 881 CTAGGGTGTCTGGCTCCTGGCGGCTTTGCCATCCATGAGGCAAGGGCTGGGAACACAGTGTCTTTGCCTATGGTAGATCC 961 ATGTGAATGTCAGGAAGCCAGCTCTTCAGTCTTGGAGATGATTTCTGCTACAATTCTGTAGAAAGATTAAGGATGGCAGA 1041 GTAAAAGGTTACCAAGAATGCCAGGATGTTTTTCTTGGGCGTAGGAGGTCCAGATTACTTTCCTTTTTGATGAAAGAGTT 1121 TGGAAGACTGTCCCATCTCTCTGGCTTGAGAAATCTCTGCCATTTTAAACATCACTGTGAAATAGCAATTATTATCATCT 1201 GTATTTAGTTTTAACATTACCCACAACATAGAAATAATAGGTAAAAATCGTCTTGCCTACTCATTCCAAAGATGATCAAG 1281 TCATTAATCTAGCAAAGTATTCATGTATCAGATTTTGTATATTTTGAATCAAAGCTAACTAGGAATGTTAGATATAAGAA 1361 TGTAATGATATTCATGCACTGAATTCTAAGCCAATATGAACAAAAATGCTGCATGAATGGCACATATAGGTCACCAAAGT 1441 TCATTCACAGGTAGAAAAAACTTGTGCTTTCTTTTCCATCTAAAAACAAAAGGAGACTTTCTTTATCTCATTTAAAGAAC 1521 AGCTCTTTGAAATTGAAATTGACCCTTTTTGCTTGACCTTAAGGAGATTAGCTTCCAGTAGATGAGTTTGCAAAATACTT 1601 TTCCTGTTCTTTTGTTTTGCTGGTATTGAAAACATCCCACTAAATCAGATGAAGAGGCATGGGAGGAAAAATATCCAAAT 1681 TAATTACTAAAATCGAGAAGAGAAGGCAAACTCTTGAAAAGTAAAAAGGTGTTTGTGACCTTCAGTATTTATTGAACAGA 1761 GGAAATAACTGACAAGGGCAATACAATTCAATGTTCATGTAGTAACATTCATGTCACTTGTTGAATTTGGTTCTCATATG 1841 TATATTGCATACACATAAATTCAAACTATAAGTCGTCATTTTTGAGCCATCATCTTACATTCATGTAATGAAATTATGGA 1921 AGAGAGTAAAAACTAGCTCTTAACTTAGTAAATATAATATGGTATTTAAAATCAGGTCACTACAGTAAGGTTCTAAGTAT 2001 TGCCAATTGAAAAGCTAGAAATGGTATTACTGTTGCAAAGTGTTGTCAATAATTGACTCCAATAGCATTGTAAATACTTG 2081 TATCCCACAACTATTTTAAACCCAAGCAATAAAATGGATTTTCTAATTCACTTCAATTCTTTATTTCTCTTACCTATCTA 2161 TGTCTTGGTACATAAGAAAAGTGTTTCCATCACTGCATTGGTAGAATTATTTCAGTGTTATTATTTTTGTGATTTCGTAT 2241 GTCTACACAAAAATGAATTAGTTTAATTTATATTGTGATACAGTTGTTTGAGAAATATTTTTAATTCTGTTTCAACTTTA 2321 TTTCTCCAAGTGTATAATATAAAAATTACTTCTGTTATTGTTCTCTACCAATAGGGGAAAAAATTAAAACATTAGATCCA 2401 TTGAGAAAGAGATGATGTAATAAATAATTAAGATTAGTAATAATATTATCAGGGGTGATTATGACCAGTTGAATAATCTC 2481 TTTCCCTTGAATTATTTAGCTAACAAATTAACTCTCCCAAATATTTAAAATAATGTAAAATCATATTTTACTGCCCATTA 2561 TTAACTAAAATATTTTTGTTTGACTTTGAGCACCAACTGGTAATACTAATAAATACCCATGTCATGCAGATGGCTGGGCG 2641 AATAAGAGATGTCTAAAAATATGCACTGGTCTTGGAAAACATGGCACAAGTAAGGATATCATATATGATGTCTGTTTATT 2721 TTATGTCTGATTTCTTTTGAATGAGTAGTTGGGGACTCCATTTCTAAGGAGACTAGGTAAATAAAATGACCTTTGACATT 2801 TCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000356457.5 | 3UTR | ACCCAUUAACCAUCUUCACCUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
74 hsa-miR-4662b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT055639 | TRUB1 | TruB pseudouridine synthase family member 1 | 2 | 4 | ||||||||
MIRT056782 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT060844 | CEP350 | centrosomal protein 350 | 2 | 2 | ||||||||
MIRT069982 | GEMIN2 | gem nuclear organelle associated protein 2 | 2 | 2 | ||||||||
MIRT071727 | CCNK | cyclin K | 2 | 2 | ||||||||
MIRT105115 | MYC | MYC proto-oncogene, bHLH transcription factor | 2 | 4 | ||||||||
MIRT122207 | TNPO1 | transportin 1 | 2 | 2 | ||||||||
MIRT125595 | SCD | stearoyl-CoA desaturase | 2 | 2 | ||||||||
MIRT164186 | SCOC | short coiled-coil protein | 2 | 2 | ||||||||
MIRT175513 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT305086 | SRPRB | SRP receptor beta subunit | 2 | 4 | ||||||||
MIRT305178 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT441913 | KRT78 | keratin 78 | 2 | 2 | ||||||||
MIRT442485 | TBC1D19 | TBC1 domain family member 19 | 2 | 2 | ||||||||
MIRT445024 | PPARA | peroxisome proliferator activated receptor alpha | 2 | 2 | ||||||||
MIRT447763 | TTLL7 | tubulin tyrosine ligase like 7 | 2 | 2 | ||||||||
MIRT447927 | SCRN1 | secernin 1 | 2 | 2 | ||||||||
MIRT450058 | IL17RA | interleukin 17 receptor A | 2 | 2 | ||||||||
MIRT452799 | FAM136A | family with sequence similarity 136 member A | 2 | 2 | ||||||||
MIRT453410 | RHD | Rh blood group D antigen | 2 | 4 | ||||||||
MIRT453687 | CEBPD | CCAAT/enhancer binding protein delta | 2 | 2 | ||||||||
MIRT455278 | DDX39B | DExD-box helicase 39B | 2 | 10 | ||||||||
MIRT457140 | ASPH | aspartate beta-hydroxylase | 2 | 2 | ||||||||
MIRT462837 | BCL3 | B-cell CLL/lymphoma 3 | 2 | 2 | ||||||||
MIRT469805 | RAB14 | RAB14, member RAS oncogene family | 2 | 2 | ||||||||
MIRT471481 | PDE7B | phosphodiesterase 7B | 2 | 2 | ||||||||
MIRT473885 | M6PR | mannose-6-phosphate receptor, cation dependent | 2 | 6 | ||||||||
MIRT474190 | LETMD1 | LETM1 domain containing 1 | 2 | 2 | ||||||||
MIRT475892 | H3F3C | H3 histone family member 3C | 2 | 8 | ||||||||
MIRT477569 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 2 | ||||||||
MIRT478765 | CS | citrate synthase | 2 | 2 | ||||||||
MIRT480210 | CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 2 | 2 | ||||||||
MIRT490709 | FSTL4 | follistatin like 4 | 2 | 2 | ||||||||
MIRT491431 | PDZD11 | PDZ domain containing 11 | 2 | 4 | ||||||||
MIRT493383 | KIAA1614 | KIAA1614 | 2 | 4 | ||||||||
MIRT493699 | H3F3B | H3 histone family member 3B | 2 | 4 | ||||||||
MIRT500563 | XBP1P1 | X-box binding protein 1 pseudogene 1 | 2 | 8 | ||||||||
MIRT502297 | GNG12 | G protein subunit gamma 12 | 2 | 6 | ||||||||
MIRT503321 | FICD | FIC domain containing | 2 | 4 | ||||||||
MIRT504119 | C9orf170 | chromosome 9 open reading frame 170 | 2 | 4 | ||||||||
MIRT506389 | NUCKS1 | nuclear casein kinase and cyclin dependent kinase substrate 1 | 2 | 4 | ||||||||
MIRT515598 | FBXL13 | F-box and leucine rich repeat protein 13 | 2 | 4 | ||||||||
MIRT517664 | TRIM72 | tripartite motif containing 72 | 2 | 4 | ||||||||
MIRT526185 | FBXO32 | F-box protein 32 | 2 | 2 | ||||||||
MIRT527110 | ARHGAP15 | Rho GTPase activating protein 15 | 2 | 2 | ||||||||
MIRT527952 | GDI2 | GDP dissociation inhibitor 2 | 2 | 2 | ||||||||
MIRT532979 | ZNF12 | zinc finger protein 12 | 2 | 2 | ||||||||
MIRT533169 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT533999 | SUZ12 | SUZ12 polycomb repressive complex 2 subunit | 2 | 2 | ||||||||
MIRT536186 | MAOB | monoamine oxidase B | 2 | 2 | ||||||||
MIRT536652 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT539222 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 6 | ||||||||
MIRT540562 | PPIC | peptidylprolyl isomerase C | 2 | 2 | ||||||||
MIRT543311 | ZNF585B | zinc finger protein 585B | 2 | 2 | ||||||||
MIRT546632 | RTN4 | reticulon 4 | 2 | 2 | ||||||||
MIRT554550 | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | 2 | 2 | ||||||||
MIRT558356 | DNAJA2 | DnaJ heat shock protein family (Hsp40) member A2 | 2 | 2 | ||||||||
MIRT561115 | CLEC2D | C-type lectin domain family 2 member D | 2 | 2 | ||||||||
MIRT565475 | SPRY1 | sprouty RTK signaling antagonist 1 | 2 | 2 | ||||||||
MIRT565551 | SMG1 | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | 2 | 2 | ||||||||
MIRT566499 | PBX2P1 | PBX homeobox 2 pseudogene 1 | 2 | 2 | ||||||||
MIRT570932 | ZNF284 | zinc finger protein 284 | 2 | 2 | ||||||||
MIRT573947 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT611173 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT643364 | TRIM10 | tripartite motif containing 10 | 2 | 2 | ||||||||
MIRT647543 | NLRP12 | NLR family pyrin domain containing 12 | 2 | 2 | ||||||||
MIRT656664 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT661960 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | 2 | 2 | ||||||||
MIRT669283 | C19orf44 | chromosome 19 open reading frame 44 | 2 | 2 | ||||||||
MIRT670210 | SLC24A4 | solute carrier family 24 member 4 | 2 | 2 | ||||||||
MIRT675813 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT676226 | TMEM91 | transmembrane protein 91 | 2 | 2 | ||||||||
MIRT694354 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT696276 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|